More importantly, we showed that DNA methylation was associated with alternative splicing and 5-Aza-CdR was able to change the exon-skipping in EZH2. This study provides valuable information on how demethylation drugs affect bladder cancer cells, thus shedding light on ongoing and future clinical trials that evaluate demethylation drugs. This evidence concerns the gene EZH2 and urinary bladder carcinoma.